These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23745443)

  • 1. [Operational mechanism modification of bone mechanostat in an animal model of nutritional stress: effect of propranolol].
    Pintos PM; Lezón CE; Bozzini C; Friedman SM; Boyer PM
    Rev Invest Clin; 2013; 65(1):39-51. PubMed ID: 23745443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA of cytokines in bone marrow and bone biomarkers in response to propranolol in a nutritional growth retardation model.
    Tasat DR; Lezón CE; Astort F; Pintos PM; Macri EV; Friedman SM; Boyer PM
    Pharmacol Rep; 2014 Oct; 66(5):867-73. PubMed ID: 25149993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved bone status by the beta-blocker propranolol in an animal model of nutritional growth retardation.
    Lezón CE; Olivera MI; Bozzini C; Mandalunis P; Alippi RM; Boyer PM
    Br J Nutr; 2009 Jun; 101(11):1616-20. PubMed ID: 19537307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical mandible competence in rats with nutritional growth retardation.
    Lezón CE; Pintos PM; Bozzini C; Romero AA; Casavalle P; Friedman SM; Boyer PM
    Arch Oral Biol; 2017 Aug; 80():10-17. PubMed ID: 28363114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of different propranolol doses on skeletal structural and mechanic efficiency in an animal model of growth retardation].
    Esteban Lezón C; Pintos PM; Itatí Olivera MI; Bozzini C; Boyer PM
    Endocrinol Nutr; 2012 Jan; 59(1):9-20. PubMed ID: 22094148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia is not associated with cardiovascular disease risk in an animal model of mild chronic suboptimal nutrition.
    Lifshitz F; Pintos PM; Lezón CE; Macri EV; Friedman SM; Boyer PM
    Nutr Res; 2012 Jan; 32(1):52-8. PubMed ID: 22260864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions.
    Bonnet N; Benhamou CL; Malaval L; Goncalves C; Vico L; Eder V; Pichon C; Courteix D
    J Cell Physiol; 2008 Dec; 217(3):819-27. PubMed ID: 18727092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet.
    Kobayashi M; Hara K; Akiyama Y
    Bone; 2004 Nov; 35(5):1136-43. PubMed ID: 15542039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-dependent effects of dietary protein concentration and quality on the biomechanical properties of the diaphyseal rat femur.
    Alippi RM; Picasso E; Huygens P; Bozzini CE; Bozzini C
    Endocrinol Nutr; 2012 Jan; 59(1):35-43. PubMed ID: 22137534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aging and dietary modulation of rat skeleton and parathyroid hormone.
    Kalu DN; Hardin RH; Cockerham R; Yu BP
    Endocrinology; 1984 Oct; 115(4):1239-47. PubMed ID: 6479092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-adrenergic blockade on physiologic growth in the Wistar rat.
    Donta I; Karayannacos PE; Boudoulas H; Kostakis A; Sechas M; Varonos D; Scalkeas GR
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):147-50. PubMed ID: 6126920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of exercise and propranolol on bone tissue in ovariectomized rats.
    Bonnet N; Beaupied H; Vico L; Dolleans E; Laroche N; Courteix D; Benhamou CL
    J Bone Miner Res; 2007 Apr; 22(4):578-88. PubMed ID: 17243867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats.
    Turner RT; Evans GL; Lotinun S; Lapke PD; Iwaniec UT; Morey-Holton E
    J Bone Miner Res; 2007 Jan; 22(1):64-71. PubMed ID: 17042715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone growth in nonorganic nutritional dwarfing rats.
    Boyer PM; Friedman SM; Olivera MI; Bozzini C; Norese MF; Rodríguez PN
    Acta Odontol Latinoam; 2000; 13(1):21-9. PubMed ID: 11885464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the histomorphometric and biomechanical properties of the proximal femur of ovariectomized rat after treatment with the phytoestrogens genistein and equol.
    Tezval M; Sehmisch S; Seidlová-Wuttke D; Rack T; Kolios L; Wuttke W; Stuermer KM; Stuermer EK
    Planta Med; 2010 Feb; 76(3):235-40. PubMed ID: 19764010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between salivary and serum markers of bone turnover in osteopenic rats.
    Pellegrini GG; Gonzales CM; Somoza JC; Friedman SM; Zeni SN
    J Periodontol; 2008 Jan; 79(1):158-65. PubMed ID: 18166106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
    Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
    Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.